For inquiries, please contact us through email or complete the form below.
Investor Inquiries
Our leadership team was chosen for their ability to address the complex and varied needs of patients with chronic metabolic and liver diseases, and their proven expertise advancing drugs from discovery through marketing approval.
Investor Inquiries